<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">38393135</PMID><DateRevised><Year>2024</Year><Month>02</Month><Day>27</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2414-6366</ISSN><JournalIssue CitedMedium="Internet"><Volume>9</Volume><Issue>2</Issue><PubDate><Year>2024</Year><Month>Feb</Month><Day>11</Day></PubDate></JournalIssue><Title>Tropical medicine and infectious disease</Title><ISOAbbreviation>Trop Med Infect Dis</ISOAbbreviation></Journal><ArticleTitle>Genomic and Phylogenetic Characterisation of SARS-CoV-2 Genomes Isolated in Patients from Lambayeque Region, Peru.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">46</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/tropicalmed9020046</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">this study aims to identify and characterise genomic and phylogenetically isolated SARS-CoV-2 viral isolates in patients from Lambayeque, Peru.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Nasopharyngeal swabs were taken from patients from the Almanzor Aguinaga Asenjo Hospital, Chiclayo, Lambayeque, Peru, which had been considered mild, moderate, and severe cases of COVID-19. Patients had to have tested positive for COVID-19, using a positive RT-PCR for SARS-CoV-2. Subsequently, the SARS-CoV-2 complete viral genome sequencing was carried out using Illumina MiSeq<sup>&#xae;</sup>. The sequences obtained from the sequence were analysed in Nextclade V1.10.0 to assign the corresponding clades, identify mutations in the SARS-CoV-2 genes and perform quality control of the sequences obtained. All sequences were aligned using MAFFT v7.471. The SARS-CoV-2 isolate Wuhan NC 045512.2 was used as a reference sequence to analyse mutations at the amino acid level. The construction of the phylogenetic tree model was achieved with IQ-TREE v1.6.12.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">It was determined that during the period from December 2020 to January 2021, the lineages s C.14, C.33, B.1.1.485, B.1.1, B.1.1.1, and B.1.111 circulated, with lineage C.14 being the most predominant at 76.7% (n = 23/30). These lineages were classified in clade 20D mainly and also within clades 20B and 20A. On the contrary, the variants found in the second batch of samples of the period from September to October 2021 were Delta (72.7%), Gamma (13.6%), Mu (4.6%), and Lambda (9.1%), distributed between clades 20J, 21G, 21H, 21J, and 21I.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">This study reveals updated information on the viral genomics of SARS-CoV-2 in the Lambayeque region, Peru, which is crucial to understanding the origins and dispersion of the virus and provides information on viral pathogenicity, transmission and epidemiology.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Aguilar-Martinez</LastName><ForeName>Sergio Luis</ForeName><Initials>SL</Initials><AffiliationInfo><Affiliation>Grupo de Investigaci&#xf3;n en Bioinform&#xe1;tica y Biolog&#xed;a Estructural, Facultad de Ciencias Biol&#xf3;gicas, Universidad Nacional Mayor de San Marcos, Lima 15081, Peru.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sandoval-Pe&#xf1;a</LastName><ForeName>Gustavo Adolfo</ForeName><Initials>GA</Initials><Identifier Source="ORCID">0000-0002-8392-9880</Identifier><AffiliationInfo><Affiliation>Grupo de Investigaci&#xf3;n en Bioinform&#xe1;tica y Biolog&#xed;a Estructural, Facultad de Ciencias Biol&#xf3;gicas, Universidad Nacional Mayor de San Marcos, Lima 15081, Peru.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Molina-Mora</LastName><ForeName>Jos&#xe9; Arturo</ForeName><Initials>JA</Initials><Identifier Source="ORCID">0000-0001-9764-4192</Identifier><AffiliationInfo><Affiliation>Centro de Investigaci&#xf3;n en Enfermedades Tropicales, Facultad de Microbiolog&#xed;a, Universidad de Costa Rica, San Jose 11501-2060, Costa Rica.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tsukayama-Cisneros</LastName><ForeName>Pablo</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0002-1669-2553</Identifier><AffiliationInfo><Affiliation>Facultad de Ciencias e Ingenier&#xed;a, Universidad Peruana Cayetano Heredia, Lima 15102, Peru.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>D&#xed;az-V&#xe9;lez</LastName><ForeName>Cristian</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0003-4593-2509</Identifier><AffiliationInfo><Affiliation>Facultad de Medicina, Universidad Privada Antenor Orrego, Trujillo 13008, Peru.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aguilar-Gamboa</LastName><ForeName>Franklin R&#xf3;mulo</ForeName><Initials>FR</Initials><Identifier Source="ORCID">0000-0003-1943-5613</Identifier><AffiliationInfo><Affiliation>Grupo de Investigaci&#xf3;n en Inmunolog&#xed;a y Virolog&#xed;a del Norte, Laboratorio de Inmunolog&#xed;a y Virolog&#xed;a, Hospital Regional Lambayeque, Lambayeque 14011, Peru.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bonilla-Aldana</LastName><ForeName>D Katterine</ForeName><Initials>DK</Initials><Identifier Source="ORCID">0000-0002-9412-2556</Identifier><AffiliationInfo><Affiliation>Research Unit, Universidad Continental, Huancayo 12001, Peru.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rodriguez-Morales</LastName><ForeName>Alfonso J</ForeName><Initials>AJ</Initials><Identifier Source="ORCID">0000-0001-9773-2192</Identifier><AffiliationInfo><Affiliation>Faculty of Health Sciences, Universidad Cient&#xed;fica del Sur, Lima 15307, Peru.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Gilbert and Rose-Marie Chagoury School of Medicine, Lebanese American University, Beirut P.O. Box 13-5053, Lebanon.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>02</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Trop Med Infect Dis</MedlineTA><NlmUniqueID>101709042</NlmUniqueID><ISSNLinking>2414-6366</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Peru</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">genome</Keyword><Keyword MajorTopicYN="N">phylogenetic analysis</Keyword><Keyword MajorTopicYN="N">sequencing</Keyword></KeywordList><CoiStatement>A.J.R.-M. has been a consultant/speaker for AstraZeneca, Valneva, and Moderna regarding COVID-19 vaccines and long COVID. The rest of the authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>11</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>2</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>2</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>2</Month><Day>23</Day><Hour>12</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>2</Month><Day>23</Day><Hour>12</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>2</Month><Day>23</Day><Hour>10</Hour><Minute>33</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>2</Month><Day>11</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38393135</ArticleId><ArticleId IdType="pmc">PMC10892787</ArticleId><ArticleId IdType="doi">10.3390/tropicalmed9020046</ArticleId><ArticleId IdType="pii">tropicalmed9020046</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Molina-Mora J.A., Reales-Gonz&#xe1;lez J., Camacho E., Duarte-Mart&#xed;nez F., Tsukayama P., Soto-Garita C., Brenes H., Cordero-Laurent E., dos Santos A.R., Salgado C.G., et al. Overview of the SARS-CoV-2 genotypes circulating in Latin America during 2021. Front. Public Health. 2023;11:1095202. doi: 10.3389/fpubh.2023.1095202.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpubh.2023.1095202</ArticleId><ArticleId IdType="pmc">PMC10018007</ArticleId><ArticleId IdType="pubmed">36935725</ArticleId></ArticleIdList></Reference><Reference><Citation>Chong Y.M., Sam I.C., Ponnampalavanar S., Omar S.F.S., Kamarulzaman A., Munusamy V., Wong C.K., Jamaluddin F.H., Gan H.M., Chong J., et al. Complete Genome Sequences of SARS-CoV-2 Strains Detected in Malaysia. Microbiol. Resour. Announc. 2020;9:e00383-20. doi: 10.1128/MRA.00383-20.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/MRA.00383-20</ArticleId><ArticleId IdType="pmc">PMC7225546</ArticleId><ArticleId IdType="pubmed">32409547</ArticleId></ArticleIdList></Reference><Reference><Citation>Juscamayta-L&#xf3;pez E., Tarazona D., Valdivia F., Rojas N., Carhuaricra D., Maturrano L., Gavil&#xe1;n R. Phylogenomics reveals multiple introductions and early spread of SARS-CoV-2 into Peru.  [(accessed on 3 October 2021)];bioRxiv. 2020  Available online:  https://www.biorxiv.org/content/10.1101/2020.09.14.296814v2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.09.14.296814v2</ArticleId><ArticleId IdType="pmc">PMC8426889</ArticleId><ArticleId IdType="pubmed">34185310</ArticleId></ArticleIdList></Reference><Reference><Citation>Aguilar-Gamboa F.R., Salcedo-Mej&#xed;a L.A., Serqu&#xe9;n-L&#xf3;pez L.M., Mechan-Llontop M.E., Tullume-Vergara P.O., Bonifacio-Brice&#xf1;o J.J., Salas-Asencios R., D&#xed;az H.S., C&#xe1;rdenas J.P. Genomic Sequences and Analysis of Five SARS-CoV-2 Variants Obtained from Patients in Lambayeque, Peru. Microbiol. Resour. Announc. 2021;10:e00789-21. doi: 10.1128/MRA.01267-20.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/MRA.01267-20</ArticleId><ArticleId IdType="pmc">PMC8407726</ArticleId><ArticleId IdType="pubmed">33414350</ArticleId></ArticleIdList></Reference><Reference><Citation>Romero P.E., D&#xe1;vila-Barclay A., Salvatierra G., Gonz&#xe1;lez L., Cuicapuza D., Solis L., Marcos-Carbajal P., Huancachoque J., Maturrano L., Tsukayama P. The Emergence of SARS-CoV-2 Variant Lambda (C.37) in South America.  [(accessed on 3 October 2021)];medRxiv. 2021  Available online:  https://www.medrxiv.org/content/10.1101/2021.06.26.21259487v1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.06.26.21259487v1</ArticleId><ArticleId IdType="pmc">PMC8549758</ArticleId><ArticleId IdType="pubmed">34704780</ArticleId></ArticleIdList></Reference><Reference><Citation>Aguilar-Gamboa F.R., Suclupe-Campos D.O., Vega-Fern&#xe1;ndez J.A., Silva-Diaz H. Diversidad gen&#xf3;mica en SARS-CoV-2: Mutaciones y variantes.  [(accessed on 14 May 2023)];Rev. Cuerpo M&#xe9;d. Hosp. Nac. Almanzor Aguinaga Asenjo. 2021 14:572&#x2013;582. doi: 10.35434/rcmhnaaa.2021.144.1465. Available online:  http://cmhnaaa.org.pe/ojs/index.php/rcmhnaaa/article/view/1465/556.</Citation><ArticleIdList><ArticleId IdType="doi">10.35434/rcmhnaaa.2021.144.1465</ArticleId></ArticleIdList></Reference><Reference><Citation>Molina-Mora J.A., Cordero-Laurent E., God&#xed;nez A., Calder&#xf3;n-Osorno M., Brenes H., Soto-Garita C., P&#xe9;rez-Corrales C., Drexler J.F., Moreira-Soto A., Corrales-Aguilar E., et al. SARS-CoV-2 genomic surveillance in Costa Rica: Evidence of a divergent population and an increased detection of a spike T1117I mutation. Infect. Genet. Evol. 2021;92:104872. doi: 10.1016/j.meegid.2021.104872.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.meegid.2021.104872</ArticleId><ArticleId IdType="pmc">PMC8065237</ArticleId><ArticleId IdType="pubmed">33905892</ArticleId></ArticleIdList></Reference><Reference><Citation>Katoh K., Standley D.M. MAFFT Multiple Sequence Alignment Software Version 7: Improvements in Performance and Usability. Mol. Biol. Evol. 2013;30:772. doi: 10.1093/molbev/mst010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/molbev/mst010</ArticleId><ArticleId IdType="pmc">PMC3603318</ArticleId><ArticleId IdType="pubmed">23329690</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen L.T., Schmidt H.A., Von Haeseler A., Minh B.Q. IQ-TREE: A fast and effective stochastic algorithm for estimating maximum-likelihood phylogenies. Mol. Biol. Evol. 2015;32:268&#x2013;274. doi: 10.1093/molbev/msu300.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/molbev/msu300</ArticleId><ArticleId IdType="pmc">PMC4271533</ArticleId><ArticleId IdType="pubmed">25371430</ArticleId></ArticleIdList></Reference><Reference><Citation>Kalyaanamoorthy S., Minh B.Q., Wong T.K.F., Von Haeseler A., Jermiin L.S. ModelFinder: Fast Model Selection for Accurate Phylogenetic Estimates. Nat. Methods. 2017;14:587. doi: 10.1038/nmeth.4285.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nmeth.4285</ArticleId><ArticleId IdType="pmc">PMC5453245</ArticleId><ArticleId IdType="pubmed">28481363</ArticleId></ArticleIdList></Reference><Reference><Citation>Letunic I., Bork P. Interactive Tree Of Life (iTOL) v4: Recent updates and new developments. Nucleic Acids Res. 2019;47:W256. doi: 10.1093/nar/gkz239.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkz239</ArticleId><ArticleId IdType="pmc">PMC6602468</ArticleId><ArticleId IdType="pubmed">30931475</ArticleId></ArticleIdList></Reference><Reference><Citation>Darvishi M., Rahimi F., Abadi A.T.B. SARS-CoV-2 Lambda (C.37): An emerging variant of concern? Gene Rep. 2021;25:101378. doi: 10.1016/j.genrep.2021.101378.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.genrep.2021.101378</ArticleId><ArticleId IdType="pmc">PMC8487850</ArticleId><ArticleId IdType="pubmed">34632160</ArticleId></ArticleIdList></Reference><Reference><Citation>Padilla-Rojas C., Jimenez-Vasquez V., Hurtado V., Mestanza O., Molina I.S., Barcena L., Ruiz S.M., Acedo S., Lizarraga W., Bailon H., et al. Genomic analysis reveals a rapid spread and predominance of lambda (C.37) SARS-CoV-2 lineage in Peru despite circulation of variants of concern. J. Med. Virol. 2021;93:6845&#x2013;6849. doi: 10.1002/jmv.27261.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.27261</ArticleId><ArticleId IdType="pmc">PMC8427000</ArticleId><ArticleId IdType="pubmed">34370324</ArticleId></ArticleIdList></Reference><Reference><Citation>Romero P.E. Escasa informaci&#xf3;n gen&#xf3;mica en bases de datos p&#xfa;blicas para investigar el SARS-CoV-2 en Latinoam&#xe9;rica. Rev. Peru. Med. Exp. Salud Publica. 2020;37:374. doi: 10.17843/rpmesp.2020.372.5396.</Citation><ArticleIdList><ArticleId IdType="doi">10.17843/rpmesp.2020.372.5396</ArticleId><ArticleId IdType="pubmed">32876233</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahmood T.B., Saha A., Hossan M.I., Mizan S., Arman S.M.A.S., Chowdhury A.S. A next-generation sequencing (NGS) analysis to reveal genomic and proteomic mutation landscapes of SARS-CoV-2 in South Asia. Curr. Res. Microb. Sci. 2021;2:100065. doi: 10.1016/j.crmicr.2021.100065.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.crmicr.2021.100065</ArticleId><ArticleId IdType="pmc">PMC8610355</ArticleId><ArticleId IdType="pubmed">34841355</ArticleId></ArticleIdList></Reference><Reference><Citation>Padilla-Rojas C., Vega-Chozo K., Galarza-Perez M., Calderon H.B., Lope-Pari P., Balbuena-Torres J., Neyra D.G., Huaringa-Nu&#xf1;ez M., Rojas-Serrano N., Caceres-Rey O.A. Genomic analysis reveals local transmission of SARS-CoV-2 in the early pandemic phase in Peru. bioRxiv. 2020 doi: 10.1101/2020.09.05.284604.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.09.05.284604</ArticleId></ArticleIdList></Reference><Reference><Citation>Tareq A.M., Emran T.B., Dhama K., Dhawan M., Tallei T.E. Impact of SARS-CoV-2 delta variant (B.1.617.2) in surging second wave of COVID-19 and efficacy of vaccines in tackling the ongoing pandemic. Hum. Vaccines Immunother. 2021;17:4126&#x2013;4127. doi: 10.1080/21645515.2021.1963601.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21645515.2021.1963601</ArticleId><ArticleId IdType="pmc">PMC8425453</ArticleId><ArticleId IdType="pubmed">34473593</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo C.H., Morris C.P., Sachithanandham J., Amadi A., Gaston D., Li M., Swanson N.J., Schwartz M., Klein E.Y., Pekosz A., et al. Infection with the SARS-CoV-2 Delta Variant is Associated with Higher Infectious Virus Loads Compared to the Alpha Variant in both Unvaccinated and Vaccinated Individuals. medRxiv. 2021 doi: 10.1101/2021.08.15.21262077.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.08.15.21262077</ArticleId><ArticleId IdType="pmc">PMC8903351</ArticleId><ArticleId IdType="pubmed">34922338</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y., Liu J., Johnson B.A., Xia H., Ku Z., Schindewolf C., Widen S.G., An Z., Weaver S.C., Menachery V.D. Delta spike P681R mutation enhances SARS-CoV-2 fitness over Alpha variant. bioRxiv. 2021 doi: 10.1016/j.celrep.2022.110829.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2022.110829</ArticleId><ArticleId IdType="pmc">PMC9050581</ArticleId><ArticleId IdType="pubmed">35550680</ArticleId></ArticleIdList></Reference><Reference><Citation>Cherian S., Potdar V., Jadhav S., Yadav P., Gupta N., Das M., Rakshit P., Singh S., Abraham P., Panda S., et al. SARS-CoV-2 Spike Mutations, L452R, T478K, E484Q and P681R, in the Second Wave of COVID-19 in Maharashtra, India. Microorganisms. 2021;9:1542. doi: 10.3390/microorganisms9071542.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/microorganisms9071542</ArticleId><ArticleId IdType="pmc">PMC8307577</ArticleId><ArticleId IdType="pubmed">34361977</ArticleId></ArticleIdList></Reference><Reference><Citation>Rahimi F., Talebi Bezmin Abadi A. Emergence of the Delta Plus variant of SARS-CoV-2 in Iran. Gene Rep. 2021;25:101341. doi: 10.1016/j.genrep.2021.101341.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.genrep.2021.101341</ArticleId><ArticleId IdType="pmc">PMC8414840</ArticleId><ArticleId IdType="pubmed">34493992</ArticleId></ArticleIdList></Reference><Reference><Citation>Nonaka C.K.V., Gr&#xe4;f T., de Lorenzo Barcia C.A., Costa V.F., de Oliveira J.L., da Hora Passos R., Bastos I.N., de Santana M.C.B., Santos I.M., de Sousa K.A.F., et al. SARS-CoV-2 variant of concern P.1 (Gamma) infection in young and middle-aged patients admitted to the intensive care units of a single hospital in Salvador, Northeast Brazil, February 2021. Int. J. Infect. Dis. 2021;111:47&#x2013;54. doi: 10.1016/j.ijid.2021.08.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2021.08.003</ArticleId><ArticleId IdType="pmc">PMC8356754</ArticleId><ArticleId IdType="pubmed">34390857</ArticleId></ArticleIdList></Reference><Reference><Citation>Vargas-Herrera N., Araujo-Castillo R.V., Mestanza O., Galarza M., Rojas-Serrano N., Solari-Zerpa L. SARS-CoV-2 Lambda and Gamma variants competition in Peru, a country with high seroprevalence. Lancet Reg. Health Am. 2022;6:100112. doi: 10.1016/j.lana.2021.100112.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lana.2021.100112</ArticleId><ArticleId IdType="pmc">PMC8600335</ArticleId><ArticleId IdType="pubmed">34812432</ArticleId></ArticleIdList></Reference><Reference><Citation>Leelawong M., Mitchell S.L., Fowler R.C., Gonzalez E., Hughes S., Griffith M.P., Marsh J.W., Harrison L.H., Rakeman J.L. SARS-CoV-2 N gene mutations impact detection by clinical molecular diagnostics: Reports in two cities in the United States. Diagn. Microbiol. Infect. Dis. 2021;101:115468. doi: 10.1016/j.diagmicrobio.2021.115468.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.diagmicrobio.2021.115468</ArticleId><ArticleId IdType="pmc">PMC8255188</ArticleId><ArticleId IdType="pubmed">34425451</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee S., Won D., Kim C.K., Ahn J., Lee Y., Na H., Kim Y.T., Lee M.K., Choi J.R., Lim H.S., et al. Novel indel mutation in the N gene of SARS-CoV-2 clinical samples that were diagnosed positive in a commercial RT-PCR assay. Virus Res. 2021;297:198398. doi: 10.1016/j.virusres.2021.198398.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virusres.2021.198398</ArticleId><ArticleId IdType="pmc">PMC7977010</ArticleId><ArticleId IdType="pubmed">33753180</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiara M., D&#x2019;Erchia A.M., Gissi C., Manzari C., Parisi A., Resta N., Zambelli F., Picardi E., Pavesi G., Horner D.S., et al. Next generation sequencing of SARS-CoV-2 genomes: Challenges, applications and opportunities. Brief. Bioinform. 2021;22:616&#x2013;630. doi: 10.1093/bib/bbaa297.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bib/bbaa297</ArticleId><ArticleId IdType="pmc">PMC7799330</ArticleId><ArticleId IdType="pubmed">33279989</ArticleId></ArticleIdList></Reference><Reference><Citation>&#xc1;lvarez-D&#xed;az D.A., Laiton-Donato K., Franco-Mu&#xf1;oz C., Mercado-Reyes M. Secuenciaci&#xf3;n del SARS-CoV-2: La iniciativa tecnol&#xf3;gica para fortalecer los sistemas de alerta temprana ante emergencias de salud p&#xfa;blica en Latinoam&#xe9;rica y el Caribe. Biomedica. 2020;40((Suppl. S2)):188. doi: 10.7705/biomedica.5841.</Citation><ArticleIdList><ArticleId IdType="doi">10.7705/biomedica.5841</ArticleId><ArticleId IdType="pmc">PMC7676827</ArticleId><ArticleId IdType="pubmed">33152203</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodriguez-Morales A.J., Balbin-Ramon G.J., Rabaan A.A., Sah R., Dhama K., Paniz-Mondolfi A., Pagliano P., Esposito S. Genomic Epidemiology and its importance in the study of the COVID-19 pandemic. Infez. Med. 2020;28:139&#x2013;142.</Citation><ArticleIdList><ArticleId IdType="pubmed">32275255</ArticleId></ArticleIdList></Reference><Reference><Citation>Rabaan A.A., Al-Ahmed S.H., Sah R., Al-Tawfiq J.A., Haque S., Harapan H., Arteaga-Livias K., Aldana D.K.B., Kumar P., Dhama K., et al. Genomic Epidemiology and Recent Update on Nucleic Acid-Based Diagnostics for COVID-19. Curr. Trop. Med. Rep. 2020;7:113&#x2013;119. doi: 10.1007/s40475-020-00212-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40475-020-00212-3</ArticleId><ArticleId IdType="pmc">PMC7513458</ArticleId><ArticleId IdType="pubmed">32989413</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodriguez-Morales A.J., Rodriguez-Morales A.G., M&#xe9;ndez C.A., Hern&#xe1;ndez-Botero S. Tracing New Clinical Manifestations in Patients with COVID-19 in Chile and Its Potential Relationship with the SARS-CoV-2 Divergence. Curr. Trop. Med. Rep. 2020;7:75&#x2013;78. doi: 10.1007/s40475-020-00205-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40475-020-00205-2</ArticleId><ArticleId IdType="pmc">PMC7165999</ArticleId><ArticleId IdType="pubmed">32313804</ArticleId></ArticleIdList></Reference><Reference><Citation>Nawab M., Riaz S.K., Ismail E., Ahamed A., Tariq A., Malik M.F.A., Qusty N.F., Bantun F., Slama P., Umair M., et al. Integrated approach for detection of SARS-CoV-2 and its variant by utilizing LAMP and ARMS-PCR. Ann. Clin. Microbiol. Antimicrob. 2024;23:11. doi: 10.1186/s12941-023-00665-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12941-023-00665-0</ArticleId><ArticleId IdType="pmc">PMC10836012</ArticleId><ArticleId IdType="pubmed">38303011</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>